Running Oak Capital LLC Acquires 16,559 Shares of Amdocs Limited (NASDAQ:DOX)

Running Oak Capital LLC increased its stake in shares of Amdocs Limited (NASDAQ:DOX - Free Report) by 21.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 94,529 shares of the technology company's stock after acquiring an additional 16,559 shares during the quarter. Running Oak Capital LLC owned about 0.08% of Amdocs worth $8,308,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Financiere des Professionnels Fonds d investissement inc. boosted its stake in Amdocs by 1.3% during the fourth quarter. Financiere des Professionnels Fonds d investissement inc. now owns 9,790 shares of the technology company's stock worth $860,000 after buying an additional 130 shares in the last quarter. First Eagle Investment Management LLC boosted its stake in Amdocs by 6.3% during the third quarter. First Eagle Investment Management LLC now owns 2,448 shares of the technology company's stock worth $207,000 after buying an additional 145 shares in the last quarter. CI Investments Inc. boosted its stake in Amdocs by 0.7% during the third quarter. CI Investments Inc. now owns 21,000 shares of the technology company's stock worth $1,774,000 after buying an additional 152 shares in the last quarter. Balentine LLC boosted its stake in Amdocs by 5.3% during the third quarter. Balentine LLC now owns 3,050 shares of the technology company's stock worth $258,000 after buying an additional 153 shares in the last quarter. Finally, Wahed Invest LLC boosted its stake in Amdocs by 9.8% during the third quarter. Wahed Invest LLC now owns 1,870 shares of the technology company's stock worth $158,000 after buying an additional 167 shares in the last quarter. Institutional investors own 92.02% of the company's stock.


Wall Street Analyst Weigh In

DOX has been the topic of a number of recent research reports. Citigroup lifted their price target on shares of Amdocs from $96.00 to $104.00 and gave the stock a "buy" rating in a research note on Wednesday, January 17th. Barclays boosted their target price on shares of Amdocs from $105.00 to $115.00 and gave the company an "overweight" rating in a research note on Thursday, February 8th. Finally, StockNews.com downgraded shares of Amdocs from a "strong-buy" rating to a "buy" rating in a research note on Friday, March 15th. Five analysts have rated the stock with a buy rating, According to MarketBeat, Amdocs presently has an average rating of "Buy" and an average price target of $108.60.

Get Our Latest Stock Report on DOX

Amdocs Price Performance

Shares of Amdocs stock traded up $0.28 during trading on Thursday, reaching $83.64. The company's stock had a trading volume of 1,112,606 shares, compared to its average volume of 659,564. The stock has a 50-day moving average price of $89.11 and a two-hundred day moving average price of $87.37. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.21. Amdocs Limited has a one year low of $78.38 and a one year high of $99.75. The stock has a market capitalization of $9.83 billion, a P/E ratio of 17.91, a price-to-earnings-growth ratio of 1.36 and a beta of 0.70.

Amdocs (NASDAQ:DOX - Get Free Report) last released its quarterly earnings results on Tuesday, February 6th. The technology company reported $1.56 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.40 by $0.16. Amdocs had a return on equity of 17.79% and a net margin of 11.30%. The business had revenue of $1.25 billion during the quarter, compared to analysts' expectations of $1.24 billion. During the same period in the previous year, the business posted $1.33 earnings per share. The firm's revenue for the quarter was up 5.0% compared to the same quarter last year. As a group, sell-side analysts anticipate that Amdocs Limited will post 5.87 EPS for the current fiscal year.

Amdocs Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, April 26th. Investors of record on Friday, March 29th were issued a $0.479 dividend. This represents a $1.92 dividend on an annualized basis and a dividend yield of 2.29%. This is a boost from Amdocs's previous quarterly dividend of $0.44. The ex-dividend date of this dividend was Wednesday, March 27th. Amdocs's payout ratio is currently 41.11%.

Amdocs Company Profile

(Free Report)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

Featured Stories

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

Should you invest $1,000 in Amdocs right now?

Before you consider Amdocs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.

While Amdocs currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Featured Articles and Offers

Search Headlines: